Regulatory tool
China cosmetic ingredient inventory search
The technical basis shared by the six ASEAN notification systems. Structurally close to the EU annexes but not identical: different transition periods, local entries, and additional national requirements.
يغطي البحث اللغتين الصينية والإنجليزية فقط — يُرجى استخدام مصطلح إنجليزي أو اسم INCI.
2,162 entries
| ID | Chemical name / description | INCI name | CAS No. | Function · Annex · Limit |
|---|---|---|---|---|
| ASEAN-II/1589 | Imidazole | — | 288-32-4 | 附录 II 禁用 · Ref 1589 |
| ASEAN-II/159 | Cyclizine (INN) and its salts | — | 82-92-8 | 附录 II 禁用 · Ref 159 |
| ASEAN-II/1590 | Lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1Hcyclopenta [d]pyrimidine-2,4(3H,5H)-dione | — | 2164-08-1 | 附录 II 禁用 · Ref 1590 |
| ASEAN-II/1591 | Metosulam (ISO); N-(2,6-dichloro-3-methylphenyl)-5,7- dimethoxy[1,2,4]triazolo[1,5-a]pyrimidine-2-sulfonamide | — | 139528-85-1 | 附录 II 禁用 · Ref 1591 |
| ASEAN-II/1592 | 2-Methyl-1-(4-methylthiophenyl)-2-morpholino-propan 1-one | — | 71868-10-5 | 附录 II 禁用 · Ref 1592 |
| ASEAN-II/1593 | 2,3-Epoxypropyl methacrylate; glycidyl methacrylate | — | 106-91-2 | 附录 II 禁用 · Ref 1593 |
| ASEAN-II/1594 | Spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspirol[4.5]decan-2- ylmethyl(ethyl)(propyl)amine | — | 118134-30-8 | 附录 II 禁用 · Ref 1594 |
| ASEAN-II/1595 | Cyanamide; carbanonitril | — | 420-04-2 | 附录 II 禁用 · Ref 1595 |
| ASEAN-II/1596 | Cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl) -3- cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | — | 94361-06-5 | 附录 II 禁用 · Ref 1596 |
| ASEAN-II/1598 | Cadmium carbonate | — | 513-78-0 | 附录 II 禁用 · Ref 1598 |
| ASEAN-II/1599 | Cadmium hydroxide; cadmium dihydroxide | — | 21041-95-2 | 附录 II 禁用 · Ref 1599 |
| ASEAN-II/16 | Alkyne alcohols, their esters, ethers and salts | — | 927-74-2 107-19-7 | 附录 II 禁用 · Ref 16 |
| ASEAN-II/160 | 5,5-Diphenyl-4-imidazolidone | — | 3254-93-1 | 附录 II 禁用 · Ref 160 |
| ASEAN-II/1600 | Cadmium nitrate; cadmium dinitrate | — | 10325-94-7 | 附录 II 禁用 · Ref 1600 |
| ASEAN-II/1601 | Dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)] stannane | — | 77-58-7 | 附录 II 禁用 · Ref 1601 |
| ASEAN-II/1602 | Clorofene; chlorophene; 2-benzyl-4-chlorophenol | — | 120-32-1 | 附录 II 禁用 · Ref 1602 |
| ASEAN-II/1603 | 9,10-anthraquinone Anthraquinone | — | 84-65-1 | 附录 II 禁用 · Ref 1603 |
| ASEAN-II/1604 | Nonadecafluorodecanoic acid [1]; Ammonium nonadecafluorodecanoate [2]; Sodium nonadecafluorodecanoate [3] | — | 335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3] | 附录 II 禁用 · Ref 1604 |
| ASEAN-II/1605 | N,N'-Methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-Methylenebismorpholine]; [MBM] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the market is ≥0,1 % w/w | — | 5625-90-1 | 附录 II 禁用 · Ref 1605 |
| ASEAN-II/1606 | Reaction products of paraformaldehyde with 2- hydroxypropylamine (3:2); [formaldehyde released from 3,3'- methylenebis[5–methyloxazolidine]; [formaldehyde released from oxazolidin]; [MBO] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture | — | — | 附录 II 禁用 · Ref 1606 |
| ASEAN-II/1607 | Reaction products of paraformaldehyde with 2- hydroxypropylamine (1:1)); [formaldehyde released from a,a,atrimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT] if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, in the mixture as placed on the marke | — | — | 附录 II 禁用 · Ref 1607 |
| ASEAN-II/1608 | Methylhydrazine | — | 60-34-4 | 附录 II 禁用 · Ref 1608 |
| ASEAN-II/1609 | Triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3- dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; a-tert-butyl-ß-(4- chlorophenoxy)-1H-1,2,4-triazole-1-ethanol | — | 55219-65-3 | 附录 II 禁用 · Ref 1609 |
| ASEAN-II/161 | Probenecid (INN) | — | 57-66-9 | 附录 II 禁用 · Ref 161 |
| ASEAN-II/1610 | Thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridyl-methyl)-1-3- thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3- yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide | — | 111988-49-9 | 附录 II 禁用 · Ref 1610 |
| ASEAN-II/1611 | Carbetamide (ISO); (R)-1-(ethylcarbamoyl) ethyl-carbanilate; (2R)- 1-(ethylamino) -1-oxopro-pan-2-yl-phenylcarbamate | — | 16118-49-3 | 附录 II 禁用 · Ref 1611 |
| ASEAN-II/1612 | Phosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2H- isoindol-2- yl)methyl]-O,O-dimethyl phosphorodithioate; O,O-dimethyl- Sphthalimidomethyl phosphorodithioate | — | 732-11-6 | 附录 II 禁用 · Ref 1612 |
| ASEAN-II/1613 | Potassium permanganate | — | 7722-64-7 | 附录 II 禁用 · Ref 1613 |
| ASEAN-II/1614 | 2-Benzyl-2-dimethylamino-4'- morpholinobutyrophenone | — | 119313-12-1 | 附录 II 禁用 · Ref 1614 |
| ASEAN-II/1615 | Quizalofop-p-tefuryl (ISO); (+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2-yloxy)phenyloxy]propionate | — | 200509-41-7 | 附录 II 禁用 · Ref 1615 |
| ASEAN-II/1616 | Propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4- triazole | — | 60207-90-1 | 附录 II 禁用 · Ref 1616 |
| ASEAN-II/1617 | Pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5- tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2- dimethylpropanoate | — | 243973-20-8 | 附录 II 禁用 · Ref 1617 |
| ASEAN-II/1618 | Tetramethrin; (1-Cyclohexene-1,2-Dicarboximido)Methyl Chrysanthemate; 2,2-Dimethyl-3-(2-Methyl-1-Propenyl) Cyclopropanecarboxylic Acid (1,3,4,5,6,7-Hexahydro-1,3-Dioxo-2H- Isoindol-2-yl)Methyl Ester | — | 7696-12-0 | 附录 II 禁用 · Ref 1618 |
| ASEAN-II/1619 | (1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1Rtrans)- 2,2-dimethyl-3-(2- methylprop-1-enyl) cyclopropanecarboxylate | — | 1166-46-7 | 附录 II 禁用 · Ref 1619 |
| ASEAN-II/162 | Disulfiram (INN); thiram (ISO) | — | 97-77-8 / 137- 26-8 | 附录 II 禁用 · Ref 162 |
| ASEAN-II/1620 | Spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo- 1- oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate | — | 148477-71-8 | 附录 II 禁用 · Ref 1620 |
| ASEAN-II/1621 | Reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1- ({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamine | — | 897393-42-9 | 附录 II 禁用 · Ref 1621 |
| ASEAN-II/1622 | 1-Vinylimidazole | — | 1072-63-5 | 附录 II 禁用 · Ref 1622 |
| ASEAN-II/1623 | Amisulbrom (ISO)3-(3-bromo-6-fluoro-2-methylindol-1- ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide | — | 348635-87-0 | 附录 II 禁用 · Ref 1623 |
| ASEAN-II/1624 | Pirimicarb (ISO); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl dimethylcarbamate | — | 23103-98-2 | 附录 II 禁用 · Ref 1624 |
| ASEAN-II/1625 | 1,2-Dichloropropane; propylene dichloride | — | 78-87-5 | 附录 II 禁用 · Ref 1625 |
| ASEAN-II/1626 | Phenol, dodecyl-, branched [1] Phenol, 2-dodecyl-, branched [2] Phenol, 3-dodecyl-, branched [3] Phenol, 4-dodecyl-, branched [4] Phenol, (tetrapropenyl) derivatives [5] | — | 121158-58-5 [1]; 1801269-80-6 [2] ; 1801269-77-1 [3]; 210555-94-5 [4]; 74499-35-7 [5] | 附录 II 禁用 · Ref 1626 |
| ASEAN-II/1627 | Coumatetralyl (ISO); 4- hydroxy-3-(1,2,3,4-tetrahydro-1- naphthyl) coumarin | — | 5836-29-3 | 附录 II 禁用 · Ref 1627 |
| ASEAN-II/1628 | Difenacoum (ISO); 3-(3- biphenyl-4-yl-1,2,3,4- tetrahydro- 1- naphthyl)- 4-hydroxycoumarin | — | 56073-07-5 | 附录 II 禁用 · Ref 1628 |
| ASEAN-II/1629 | Brodifacoum (ISO); 4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)- 1,2,3,4-tetrahydro-1-naphthyl)coumarin | — | 56073-10-0 | 附录 II 禁用 · Ref 1629 |
| ASEAN-II/163 | Emetine, its salts and derivatives | — | 483-18-1 | 附录 II 禁用 · Ref 163 |
| ASEAN-II/1630 | Flocoumafen (ISO); reaction mass of: cis-4- hydroxy-3- (1,2,3,4- tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1- naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4- tetrahydro-3-(4- (4-trifluoromethylbenzyloxy)phenyl)-1- naphthyl)coumarin | — | 90035-08-8 | 附录 II 禁用 · Ref 1630 |
| ASEAN-II/1631 | Acetochlor (ISO); 2- chloro-N-(ethoxymethyl)-N-(2-ethyl-6- methylphenyl)acetamide | — | 34256-82-1 | 附录 II 禁用 · Ref 1631 |
| ASEAN-II/1632 | e-Glass microfibres of representative composition | — | — | 附录 II 禁用 · Ref 1632 |
| ASEAN-II/1633 | Glass microfibres of representative composition | — | — | 附录 II 禁用 · Ref 1633 |
Source: ASEAN Secretariat. Reproduced from the official list without additions or changes. Listing is not approval; limits and conditions follow the latest official text.
Need to confirm whether an ingredient is usable in your target market? Send us the formulation direction.